Hepion Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-12.324; its P/E ratio is -0.17; Hepion Pharmaceuticals is scheduled to report earnings on May 15, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -11.43M	$ -10.52M	$ -14.08M	$ -13.26M	$ -10.12M
EBITDA	$ -11.42M	$ -10.51M	$ -14.06M	$ -13.24M	$ -10.11M
Net Income Common Stockholders	$ -11.06M	$ -10.53M	$ -14.08M	$ -13.26M	$ -9.96M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 14.79M	$ 19.28M	$ 30.52M	$ 42.99M	$ 51.19M
Total Assets	$ 18.09M	$ 25.00M	$ 36.50M	$ 49.50M	$ 60.24M
Total Debt	$ 209.02K	$ 241.54K	$ 0.00	$ 0.00	$ 53.61K
Net Debt	$ -14.58M	$ -19.04M	$ -30.52M	$ -42.99M	$ -51.14M
Total Liabilities	$ 10.81M	$ 8.84M	$ 10.13M	$ 12.34M	$ 10.39M
Stockholders Equity	$ 7.28M	$ 16.16M	$ 26.37M	$ 37.15M	$ 49.86M
Cash Flow	-
Free Cash Flow	$ -9.00M	$ -11.20M	$ -12.52M	$ -8.26M	$ -4.82M
Operating Cash Flow	$ -9.00M	$ -11.20M	$ -12.50M	$ -8.26M	$ -4.80M
Investing Cash Flow	$ -348.00	$ 2.58K	$ -16.54K	$ 48.43K	$ -16.34K
Financing Cash Flow	$ 4.49M	-	-	-	$ -3.14M

Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History

Income Statement >

Hepion Pharmaceuticals Debt to Assets

Balance Sheet >

Hepion Pharmaceuticals Cash Flow

Cash Flow >

Hepion Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing